Condition
Amyloidosis Cardiac clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Amyloidosis Cardiac clinical trials that are recruiting, at sites in 6 countries (most in Germany (3), United States (2), Italy (2)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 6Countries
Newest Amyloidosis Cardiac clinical trials
All recruiting trials (10)
-
Detecting cardiac amyloidosis in people with severe aortic valve narrowing
This study tests non-invasively whether imaging tests can find heart amyloidosis in patients with severe aortic stenosis who are being evaluated for valve replacement.
-
Multimodal analysis of heart biopsy samples
This project will take one extra small heart biopsy during a clinically needed procedure to test whether detailed molecular and immune analyses can find disease-specific signatures in adults with cardiomyopathies, myocarditis, cardiac amyloidosis, or after heart transplant.
-
Using tiny blood particles to detect and track ATTR heart amyloidosis
This project will test whether tiny blood particles called extracellular vesicles can help detect and track transthyretin (ATTR) amyloid cardiomyopathy in people with or at risk for ATTR.
-
Belgian Amyloidosis Biobank and Patient Registry at UZ Leuven
This project collects and stores blood, tissue samples, and medical data from adults with suspected or confirmed amyloidosis to create a biobank and registry for future research.
-
PET, MRI and ultrasound to track heart changes in ATTR cardiac amyloidosis
This study will try PET, MRI and ultrasound scans in people with ATTR cardiac amyloidosis starting tafamidis to see if the new images explain why some patients keep getting worse.
-
Registry for patients with systemic amyloidosis
This study is collecting information from patients with systemic amyloidosis to better understand the disease and how different treatments work over time.
-
Identifying patients with cardiomyopathy for potential heart transplantation
This study is trying to find new ways to identify and understand cardiomyopathy in patients to better predict if they might need a heart transplant in the future.
-
Evaluation of heart health in patients with ATTR amyloidosis on tafamidis treatment
This study looks at how tafamidis treatment affects heart health in patients with ATTR amyloidosis by checking their heart rhythm and other health needs every six months.
-
Investigating early signs of heart disease in specific genetic carriers
This study is trying to find early signs of heart disease in people with a specific genetic mutation linked to a heart condition called amyloidosis to help catch the disease sooner.
-
Ultrasound therapy for cardiac amyloidosis
This study is testing whether ultrasound therapy can improve heart blood flow and function in people with cardiac amyloidosis.
Related topics
Quick answers
How many Amyloidosis Cardiac clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Germany (3 trials), United States (2 trials), Italy (2 trials), Switzerland (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.